Alongside the raised hazard for coronavirus infection 2019 (COVID-19)- related difficulties in patients with hidden ailments, for example, diabetes and cardiovascular sickness, people with immune system illnesses may likewise confront a few dangers identified with their condition and the idea of their treatment.

Specialists assessed the dangers and advantages of proceeding with upkeep immunosuppression for patients contaminated with or in danger of contracting serious intense respiratory disorder coronavirus 2 (SARS-CoV-2). While treatment choices ought to at last be resolved in a joint dynamic procedure among patient and supplier, the specialists of this report proposed that it might be suitable to hold off on immunosuppression for about fourteen days in patients with affirmed introduction to or with side effects of COVID-19, with proceeded with treatment for those with no proof of presentation to the infection.

There is additionally worry that immune compromised patients might be progressively powerless to pneumonia, as has been noted with different kinds of coronaviruses. Some immunomodulatory treatments, including chloroquine, tocilizumab, and baricitinib, may present defensive impacts against the "cytokine storm" that has been seen in patients with serious COVID-19 pneumonia.

Regards
Jessie Franklin
Managing Editor
Rheumatology: Current Research
E-mail id: rheumatology@eclinicalsci.com
Submit Manuscript at: https://www.longdom.org/submissions/rheumatology-current-research.html